American Society for Radiation Oncology (ASTRO) | sciencenewsnet.in

Breaking News

Dolphin Serum Protects Blood Vessel Function in Older Mice

Cannabis Exposure during Pregnancy Had Sex-dependent Effects on Rats’ Breathing in Adult Offspring

Older Women Are at Greater Risk of Heat Stress Than Older Men

Type 2 Diabetes Medication Improves Liver Health in Mice Fed High Fat Diet

77-year-old Marathon World-record Holder Showed Elevated VO2Max, Heart Remodeling after Lifetime of Endurance Exercise

Disruptions to Cholesterol in Cells Is an Early Sign of Beta Cell Damage in Model of Type 2 Diabetes

Disruptions to Fatty Compounds Inside Muscle Cells Coincides with Model of Cancer-induced Muscle Wasting

Model of Running Outcomes Could Inform Training for Different Groups

Rutgers Inventors Receive Edison Patent Awards in Industrial Processes, Medical Diagnostics Categories

Postdoc Takes Multipronged Approach to Muon Detection

08 Sep, 2024

Winners of the ASTRO-Sumitomo Pharma-Pfizer Alliance new combination therapy challenge announced

September 27, 2023 sarah JonasAnnouncement

The American Society for Radiation Oncology (ASTRO) today announced the three winning research proposals for the 2022 ASTRO-Myovant Sciences (now known as Sumitomo Pharma)-Pfizer Alliance New Combination (Relugolix-Radiation) Therapy Challenge.